Targeting RNA Congress Nearly 100% of all small molecule drugs in the market are designed to target proteins. However, only 2% of the human genome actually codes for proteins, leaving the remaining noncoding DNA and in turn RNA as potentially untapped therapeutic targets. To date, industry has focused on biological products for RNA therapeutics but […]

At a time when the previously untapped drug discovery opportunity promised within RNA opens up, the 2nd RNA- Targeted Drug Discovery Summit returns to reunite the leading minds from large pharma, innovative biotech and KOLs of academia to discuss unique discovery and development challenges that must be overcome for novel RNA targeted small molecule therapeutics […]

The 3rd Microbiome Movement – Gut-Brain Axis Summit is returning to Boston this December and will unite pioneering industry and academic researchers to establish the mechanistic pathways contributing to neurological disorder manifestation, overcome the scientific and translational challenges of working in the gut-brain setting and capitalize on this therapeutic opportunity. This meeting provides the opportunity for you to: […]

Now in its 5th year, the Oncolytic Virotherapy Summit is the industry’s definitive guide to turning viral vehicles into clinically effective therapeutics across oncology indications. With 3 days of in-depth cutting-edge case studies and the highest calibre of industry discussions, The OV Summit will provide the roadmap to oncolytic virotherapy success. Hear from pharma and […]

With the rapid rise of digital technology and shifts within the larger healthcare industry, the need to find new talent that can drive innovation has never been more critical. HR Life Sciences is specifically designed for senior HR professionals at the nation's leading Pharmaceutical, Biotech and Medical Device companies. You'll discover the tools, insights, innovations, […]

The 8th annual PREDiCT: Tumour Models London Summit will return this December with a new speaker faculty to help you benchmark your oncology model selection strategy and target validation. With the rise of immuno-oncology, model requirements, target validation and the importance of tumour micro-environment are key to clinical success. The 3-days summit will provide you […]

SMi are pleased to announce the launch of the Respiratory Drug Delivery conference as part of the newly branded Asthma and COPD series, which will be held in London on the 5th – 6th December 2019. With the rising prevalence of respiratory disease such as Asthma, cystic fibrosis and COPD, this group of diseases are […]

The explosion in cell therapy development companies has fueled a need to develop well-characterized clinical products which has resulted in the call for robust and validated analytical assays now being louder and more important than ever before. The inaugural Cell Therapy Analytical Development Summit brings you the leaders in CMC, analytics and process development to […]

EARLY-STAGE INNOVATIONS | ACADEMIA-INDUSTRY COLLABORATIONS | TECHNOLOGY TRANSFER | SEED INVESTMENT With the highest attending rate of TTOs, research institutes and academia together with big pharma, emerging and small biotech, diagnostics companies, pre-seed / seed / Series A investors, BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovation […]